ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,221Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 86

$5.03M Total Retail Price of All Prescriptions

Rank: 1 out of 86

386 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 2,019 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

64% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$492 was the average price of a prescription from this provider, compared to $288 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
NORVIR 957 147 10 1 1
PREZISTA 580 87 10 2 7
ISENTRESS 495 101 3 4
TRUVADA 494 65 4 2
REYATAZ 294 51 5 6
EPZICOM 267 69 6 13
INTELENCE 225 47 7 43
KALETRA 215 15 8 23
CRESTOR 206 69 9 9
AMLODIPINE BESYLATE 203 70 10 3
ATRIPLA 176 71 11 10
HYDROCHLOROTHIAZIDE 170 51 12 22
PROAIR HFA 138 24 13 19
LAMIVUDINE 134 31 10 14 72
SELZENTRY 130 0 10 15 114
NEXIUM 128 27 16 14
ENALAPRIL MALEATE 124 52 17 24
ZOLPIDEM TARTRATE 119 0 18 11
LOSARTAN-HYDROCHLOROTHIAZIDE 119 24 18 41
ATORVASTATIN CALCIUM 118 37 20 12
METOPROLOL TARTRATE 110 33 21 26
ADVAIR DISKUS 109 0 22 32
ENDOCET 109 0 S2 22 18
CYMBALTA 105 0 24 87
LEXIVA 100 29 25 57
GABAPENTIN 96 28 26 25
METFORMIN HCL 89 16 27 17
METOPROLOL SUCCINATE 78 36 28 15
COMPLERA 77 0 29 111
IBUPROFEN 76 0 30 65
TRAMADOL HCL-ACETAMINOPHEN 71 24 31 92
LOSARTAN POTASSIUM 70 26 32 60
VIREAD 68 0 33 36
OMEPRAZOLE 66 20 34 8
TAMSULOSIN HCL 63 22 35 45
CLOTRIMAZOLE-BETAMETHASONE 61 12 36 42
LYRICA 60 0 37 69
AZITHROMYCIN 59 0 38 28
VALACYCLOVIR 58 12 39 46
KETOCONAZOLE 58 0 39 102
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 0 41 30
TRAZODONE HCL 55 11 42 175
DIOVAN HCT 52 0 43 20
EPIVIR 51 0 44 181
AMOX TR-POTASSIUM CLAVULANATE 50 0 45 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.